COVID-19 associated lung cavitary lesions: A case series.

Pub Date : 2024-09-07 eCollection Date: 2024-01-01 DOI:10.22088/cjim.15.4.713

Rama Bozorgmehr, Farzad Esmaili Tarki, Esmat Yazdi, Shahrzad Shahrokhi Nejad

{"title":"COVID-19 associated lung cavitary lesions: A case series.","authors":"Rama Bozorgmehr, Farzad Esmaili Tarki, Esmat Yazdi, Shahrzad Shahrokhi Nejad","doi":"10.22088/cjim.15.4.713","DOIUrl":null,"url":null,"abstract":"Background: Our study discusses the probable etiologies and characteristics of pulmonary cavities in post-COVID-19 patients. A pulmonary cavity is a late complication of the disease, yet it has led to multiple referrals to our tertiary hospital in Tehran, Iran.Methods: We conducted a retrospective case-series study on 20 patients who were admitted to our center between April 2020 and September 2021. They were all diagnosed with COVID-19 and concomitantly developed pulmonary cavities. We assessed their electronic medical records in 2021 and compared their characteristics with other studies based on the available literature.Result: Of the 20 patients with cavities, 12 (60%) had been diagnosed with prior COVID-19, and 9 (45%) had type 2 diabetes mellitus. 9 patients (45%) had bacterial superinfections while 4 (44%) had fungal infections. All patients received corticosteroids, but only 4 (20%) were additionally administered Tocilizumab.Conclusion: COVID-19 patients can develop pulmonary cavities during recovery; however, this infrequent radiologic finding depends on specific risk factors.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444108/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22088/cjim.15.4.713","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Our study discusses the probable etiologies and characteristics of pulmonary cavities in post-COVID-19 patients. A pulmonary cavity is a late complication of the disease, yet it has led to multiple referrals to our tertiary hospital in Tehran, Iran.

Methods: We conducted a retrospective case-series study on 20 patients who were admitted to our center between April 2020 and September 2021. They were all diagnosed with COVID-19 and concomitantly developed pulmonary cavities. We assessed their electronic medical records in 2021 and compared their characteristics with other studies based on the available literature.

Result: Of the 20 patients with cavities, 12 (60%) had been diagnosed with prior COVID-19, and 9 (45%) had type 2 diabetes mellitus. 9 patients (45%) had bacterial superinfections while 4 (44%) had fungal infections. All patients received corticosteroids, but only 4 (20%) were additionally administered Tocilizumab.

Conclusion: COVID-19 patients can develop pulmonary cavities during recovery; however, this infrequent radiologic finding depends on specific risk factors.

查看原文

与 COVID-19 相关的肺空洞性病变：病例系列

背景：我们的研究探讨了 COVID-19 后患者肺空洞的可能病因和特征。肺空洞是该病的晚期并发症，但它却导致多人转诊至我们位于伊朗德黑兰的三级医院：我们对 2020 年 4 月至 2021 年 9 月期间入住本中心的 20 名患者进行了回顾性病例系列研究。他们均被诊断为 COVID-19，并同时出现肺空洞。我们评估了他们在2021年的电子病历，并根据现有文献将他们的特征与其他研究进行了比较：结果：在 20 名龋齿患者中，12 人（60%）曾被诊断患有 COVID-19，9 人（45%）患有 2 型糖尿病。9名患者（45%）患有细菌性超级感染，4名患者（44%）患有真菌感染。所有患者都接受了皮质类固醇治疗，但只有4名患者（20%）额外使用了托珠单抗：结论：COVID-19 患者在康复期间可能会出现肺空洞，但这种不常见的放射学发现取决于特定的风险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文